NR3C2 and obesity disorder: SMC-MR deletion mitigated obesity-associated cardiac and coronary inflammation and dysfunction, but not hypertrophy, potentially involving reduced cardiac mast cells and enhanced SMC estrogen signaling that warrant further investigation.